RESEARCH TRIANGLE PARK, N.C., Sept. 19, 2023 -- Pappas Capital, a leading investor in next-generation life science and technology companies, announced today that Nick Pappas (no relation) has joined the firm as...
BrainCells and Organon to collaborate in discovery and development of CNS drugs
News | 10. 23. 2006
BrainCells
BrainCells Inc. (BCI) and Organon, the human health care business unit of Akzo Nobel (Nasdaq: AKZOY), today announced they will collaborate in the discovery and development of drugs for the treatment of central nervous system (CNS) disorders.
